Skip to main content Accessibility help
Hostname: page-component-7479d7b7d-jwnkl Total loading time: 0 Render date: 2024-07-15T18:04:18.478Z Has data issue: false hasContentIssue false

Chapter 4 - Contribution of RADx® Tech to the Rapid Development of COVID-19 Diagnostic Tests

Published online by Cambridge University Press:  06 January 2024

Steven C. Schachter
Harvard Medical School
Wade E. Bolton
VentureWell/Rapid Acceleration of Diagnostics (RADx)
Get access


Rapid Acceleration of Diagnostics (RADx®) Tech was the key diagnostics component of a three-pronged national strategy, including vaccines and therapeutics, to respond to the COVID-19 pandemic. Unprecedented in the scale of its mission, its budget, its accelerated time frame, the extent of cross-government agency collaboration and information exchange, and the blending of business, academic, and investment best practices, RAD Tech successfully launched dozens of US Food and Drug Administration Emergency Use Authorization diagnostic tests, established a new model for rapidly translating diagnostic tests from the laboratory to the marketplace, and accelerated public acceptance of home-based diagnostic tests. This chapter provides an overview of the processes utilized by RADx Tech during the COVID-19 pandemic to improve clinical laboratory tests and identify, evaluate, support, validate, and commercialize innovative point-of-care and home-based tests that directly detected the presence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus.

Accelerating Diagnostics in a Time of Crisis
The Response to COVID-19 and a Roadmap for Future Pandemics
, pp. 74 - 87
Publisher: Cambridge University Press
Print publication year: 2024

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)


Taylor, R., Health officials Senate testimony transcript on new tests for COVID-19 (May 7, 2020). Scholar
Alexander, L. and Blunt, R., Opinion: we need more covid-19 tests. We propose a “shark tank” to get us there, Washington Post (April 20, 2020). Scholar
Carleton, P.F., Schachter, S., Lash, T. B., et al., Point-of-Care Technology Research Network: an evolving model for collaborative translational research in biomedical engineering. Curr Opin Biomed Eng, 11 (2019), 145148.CrossRefGoogle Scholar
Tromberg, B. J., Schwetz, T. A., Pérez-Stable, E. J., et al., Rapid scaling up of Covid-19 diagnostic testing in the United States – the NIH RADx initiative. N Engl J Med, 383, 11 (2020), 10711077.CrossRefGoogle ScholarPubMed
Collins, J. M., Collins, M. R., McKenzie, T., and Marino, M., The role of CoLab and GAITS in enabling the RADx Tech program. IEEE Open J Eng Med Biol, 2 (2021), 119124.CrossRefGoogle ScholarPubMed
Gibson, L., Fahey, N., Hafer, N., et al., The RADx Tech Clinical Studies Core: a model for academic based clinical studies. IEEE Open J Eng Med Biol, 2 (2021), 152157.CrossRefGoogle Scholar
Soni, A., Herbert, C., Filippaios, A., et al., Comparison of rapid antigen tests’ performance between delta and omicron variants of SARS-CoV-2: a secondary analysis from a serial home self-testing study. Ann Intern Med, 175, 12 (2022), 16851692.CrossRefGoogle ScholarPubMed
Soni, A., Herbert, C., Lin, H., et al., Performance of rapid antigen tests to detect symptomatic and asymptomatic SARS-CoV-2 infection. medRxiv (2022), Scholar
Robinson, M., Gaydos, C., Van Der Pol, B., et al., The Clinical Review Committee: impact of the development of in vitro diagnostic tests for SARS-CoV-2 within RADx Tech. IEEE Open J Eng Med Biol, 2 (2021), 138141.CrossRefGoogle ScholarPubMed
Tessier, P., Dempsey, M., Collins, J., and Schachter, S., RADx Tech Viability and Steering Panels: a model for MedTech translational grant review. IEEE Open J Eng Med Biol, 2 (2021), 125130.CrossRefGoogle Scholar
Dempsey, M., Tessier, P., Collins, J., and Caro, E., The RADx Tech deep dive and work package 1 process. IEEE Open J Eng Med Biol, 2 (2021), 131137.Google Scholar
FDA, At-Home COVID-19 Antigen Tests-Take Steps to Reduce Your Risk of False Negative Results: FDA Safety Communication. Updated November 17, 2022 (2022). Scholar
POCTRN, RADx Tech webinar series 2023. (accessed January 29, 2023).Google Scholar
Akay, M., Subramaniam, S., Brennan, C., et al., Healthcare innovations to address the challenges of the COVID-19 pandemic. IEEE J Biomed Health Inform, 26, 7 (2022), 32943302.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the or variations. ‘’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats